Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Leaf MobileAurora CannabisZomedicaHEXOOrganiGram
SymbolTSE:LEAFTSE:ACBNYSEAMERICAN:ZOMTSE:HEXOTSE:OGI
Price Information
Current PriceC$0.38C$9.84$0.85C$6.90C$3.14
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score1.21.00.90.71.2
Analysis Score3.51.81.51.32.9
Community Score2.52.63.02.11.8
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.60.00.01.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price TargetC$0.75C$11.91$0.30C$1.79C$3.77
% Upside from Price Target97.37% upside21.08% upside-64.71% downside-74.07% downside20.00% upside
Trade Information
Market CapC$2.47 billionC$1.95 billion$479.44 millionC$844.46 millionC$936.45 million
BetaN/AN/AN/AN/AN/A
Average Volume913,7424,808,771162,631,4382,401,9224,713,359
Sales & Book Value
Annual RevenueC$19.24 millionC$285.54 millionN/AC$111.62 millionC$72.40 million
Price / Sales15.106.82N/A7.5712.94
CashflowC$0.02 per shareC$1.97 per shareN/AC$1.06 per shareC$0.30 per share
Price / Cash20.285.00N/A6.5310.30
Book ValueC$0.04 per shareC$11.93 per shareN/AC$4.42 per shareC$1.15 per share
Price / Book8.640.82N/A1.562.74
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.01)C($19.34)N/AC($2.02)C($1.14)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/A0.13
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%22.46%N/A16.03%22.01%
Current Ratio2.02%4.96%N/A4.30%6.66%
Quick Ratio1.93%3.11%N/A2.37%4.11%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/A2,73119374516
Shares Outstanding764.38 million197.98 million564.05 million122.39 million298.23 million
Next Earnings DateN/A5/13/2021 (Estimated)5/10/2021 (Estimated)6/9/2021 (Estimated)7/20/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
SourceHeadline
Analysts Are More Bearish On OrganiGram Holdings Inc. (TSE:OGI) Than They Used To Be - Yahoo FinanceAnalysts Are More Bearish On OrganiGram Holdings Inc. (TSE:OGI) Than They Used To Be - Yahoo Finance
finance.yahoo.com - April 18 at 8:56 AM
OrganiGram Holdings Inc (NASDAQ:OGI) Reports Revenues Of $19.292 Million In Q2 2021: Introduces Three Innovative Indica Strains - DRP GazetteOrganiGram Holdings Inc (NASDAQ:OGI) Reports Revenues Of $19.292 Million In Q2 2021: Introduces Three Innovative Indica Strains - DRP Gazette
drpgazette.com - April 17 at 2:57 PM
New Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More - Report DoorNew Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More - Report Door
reportdoor.com - April 17 at 12:20 PM
The Week In Cannabis: New Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More - Yahoo FinanceThe Week In Cannabis: New Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More - Yahoo Finance
finance.yahoo.com - April 16 at 11:22 PM
Organigram Earnings: Canaccord Raises Target While Others Cut - The Deep DiveOrganigram Earnings: Canaccord Raises Target While Others Cut - The Deep Dive
thedeepdive.ca - April 15 at 12:01 PM
Alliance Global Partners Cuts OrganiGram (TSE:OGI) Price Target to C$3.75Alliance Global Partners Cuts OrganiGram (TSE:OGI) Price Target to C$3.75
americanbankingnews.com - April 15 at 9:50 AM
5 Major Organigram Price Target Changes Investors Need To Know - Technical420 - Technical4205 Major Organigram Price Target Changes Investors Need To Know - Technical420 - Technical420
technical420.com - April 15 at 7:45 AM
Q2 2021 EPS Estimates for OrganiGram Holdings Inc. (TSE:OGI) Cut by OppenheimerQ2 2021 EPS Estimates for OrganiGram Holdings Inc. (TSE:OGI) Cut by Oppenheimer
americanbankingnews.com - April 15 at 6:50 AM
OrganiGram: Fiscal Q2 Earnings Snapshot - San Antonio Express-NewsOrganiGram: Fiscal Q2 Earnings Snapshot - San Antonio Express-News
expressnews.com - April 14 at 3:58 PM
Canaccord Genuity Increases OrganiGram (TSE:OGI) Price Target to C$3.50Canaccord Genuity Increases OrganiGram (TSE:OGI) Price Target to C$3.50
americanbankingnews.com - April 14 at 2:56 PM
ATB Capital Trims OrganiGram (TSE:OGI) Target Price to C$3.75ATB Capital Trims OrganiGram (TSE:OGI) Target Price to C$3.75
americanbankingnews.com - April 14 at 2:56 PM
OrganiGram (TSE:OGI) Given New C$4.00 Price Target at Alliance Global PartnersOrganiGram (TSE:OGI) Given New C$4.00 Price Target at Alliance Global Partners
americanbankingnews.com - April 14 at 2:56 PM
Haywood Securities Trims OrganiGram (TSE:OGI) Target Price to C$3.50Haywood Securities Trims OrganiGram (TSE:OGI) Target Price to C$3.50
americanbankingnews.com - April 14 at 2:56 PM
OrganiGram (TSE:OGI) Downgraded by CIBCOrganiGram (TSE:OGI) Downgraded by CIBC
americanbankingnews.com - April 14 at 10:30 AM
OrganiGram shares drop 8% on revenue miss citing staffing limitations due to COVID-19 - Seeking AlphaOrganiGram shares drop 8% on revenue miss citing staffing limitations due to COVID-19 - Seeking Alpha
seekingalpha.com - April 14 at 5:56 AM
Organigram Posts Poor 2021 Second Quarter - 91.9 The BendOrganigram Posts Poor 2021 Second Quarter - 91.9 The Bend
919thebend.ca - April 14 at 5:56 AM
Organigram Down On COVID-19 Impact, Buying Opportunity In Sight - EntrepreneurOrganigram Down On COVID-19 Impact, Buying Opportunity In Sight - Entrepreneur
entrepreneur.com - April 14 at 5:56 AM
Organigram price target cut to $5.00 at Raymond JamesOrganigram price target cut to $5.00 at Raymond James
cantechletter.com - April 14 at 12:55 AM
What Did We Discover About Insider Trading At OrganiGram Holdings Inc. (NASDAQ:OGI)?What Did We Discover About Insider Trading At OrganiGram Holdings Inc. (NASDAQ:OGI)?
stocksregister.com - April 13 at 2:54 PM
Why OrganiGrams Q2 Results Were So UglyWhy OrganiGram's Q2 Results Were So Ugly
msn.com - April 13 at 2:54 PM
OrganiGram: Fiscal Q2 Earnings Snapshot - New Canaan AdvertiserOrganiGram: Fiscal Q2 Earnings Snapshot - New Canaan Advertiser
ncadvertiser.com - April 13 at 2:54 PM
OrganiGram (TSE:OGI) PT Set at C$6.00 by Raymond JamesOrganiGram (TSE:OGI) PT Set at C$6.00 by Raymond James
americanbankingnews.com - April 13 at 9:48 AM
OrganiGram Holdings Inc. (NASDAQ:OGI) surprises Wall Street with -3.17% stock price lossOrganiGram Holdings Inc. (NASDAQ:OGI) surprises Wall Street with -3.17% stock price loss
marketingsentinel.com - April 13 at 9:46 AM
Organigram Q2 Revenue Slides 24% Sequentially to C$14.6 MillionOrganigram Q2 Revenue Slides 24% Sequentially to C$14.6 Million
newcannabisventures.com - April 13 at 9:46 AM
OrganiGram: Fiscal Q2 Earnings SnapshotOrganiGram: Fiscal Q2 Earnings Snapshot
sfgate.com - April 13 at 9:46 AM
OrganiGram (TSE:OGI) Given a C$6.00 Price Target at Raymond JamesOrganiGram (TSE:OGI) Given a C$6.00 Price Target at Raymond James
marketbeat.com - April 7 at 2:13 PM
DateCompanyBrokerageAction
2/12/2021Leaf MobileHaywood SecuritiesSet Price Target
6/20/2018Leaf MobilePi FinancialDowngrade
5/15/2018Leaf MobileEight CapitalDowngrade
5/15/2018Leaf MobileCormarkDowngrade
5/8/2018Leaf MobileBeacon SecuritiesReiterated Rating
2/24/2021Aurora CannabisJefferies Financial GroupBoost Price Target
2/16/2021Aurora CannabisCIBCBoost Price Target
2/12/2021Aurora CannabisCanaccord GenuityBoost Price Target
2/12/2021Aurora CannabisMKM PartnersReiterated Rating
2/12/2021Aurora CannabisStifel NicolausBoost Price Target
2/12/2021Aurora CannabisATB CapitalBoost Price Target
11/16/2020Aurora CannabisAtb Cap MarketsUpgrade
11/10/2020Aurora CannabisCowenBoost Price Target
11/9/2020Aurora CannabisCantor FitzgeraldDowngrade
11/16/2020ZomedicaHC WainwrightLower Price Target
11/2/2020HEXOStandpoint ResearchLower Price Target
4/15/2020HEXOAlliance Global PartnersLower Price Target
4/13/2021OrganiGramRaymond JamesLower Price Target
(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.